Friday, October 23, 2026

11:30 AM - 12:15 PM

Investment & Global Growth Breakout Room

---

Details

What separates a promising asset from a fundable, partnerable biotech opportunity? The answer often lies in the decisions made before the first patient enters a clinical trial. Regulatory strategy, development planning, commercial environment knowledge, reimbursement and payer management, capital allocation, and operational execution all play a critical role in determining whether a program will create value and attract the attention of investors and strategic partners. In this session, the experienced panel of biotech executives, investors, partnering leaders and clinical development specialists will discuss real-world examples of successful value creation from the outset. The conversation will focus on creating a development pathway that support investment readiness, strategic partnerships, licensing opportunities and ultimately successful exits. Through the shared experience covering founders, developers, buyers, and investors, this session will provide a unique viewpoint on how Australian developers can build success locally and internationally.

---

Speaker